Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
World Journal of Gastrointestinal Pathophysiology|June 4, 2014
Prevention of post-ERCP pancreatitisLin-Lee Wong, Her-Hsin Tsai
Expert Review of Pharmacoeconomics & Outcomes Research|October 12, 2016
A review of the cost-effectiveness of vedolizumab for treating moderate- to severely active ulcerative colitisHer Hsin Tsai, Christopher Black
BMJ Case Reports|September 11, 2016
Eosinophilic gastroenteritis: a challenge to diagnose and treatNaw April Phaw, Her Hsin Tsai
World Journal of Gastrointestinal Pharmacology and Therapeutics|February 9, 2016
Review of vedolizumab for the treatment of ulcerative colitisMichelle Sy Lau, Her Hsin Tsai
World Journal of Gastroenterology|December 24, 2013
Novel therapies for constipationSreedhari Thayalasekeran, Hani Ali, Her-Hsin Tsai
Digestive Diseases (Basel, Switzerland)|May 4, 2017
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?Lin Lee Wong, Vinod S Hegade, David E J Jones
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Symptoms of PBC - Pathophysiology and managementAmardeep Khanna, Jess Leighton, Lin Lee Wong, et al.
BMC Gastroenterology|September 16, 2016
'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'Michelle Shui Yee Lau, Peter Mooney, William White, et al.
Digestive Diseases and Sciences|July 21, 2016
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk ScoreVinod S Hegade, Amardeep Khanna, Lucy J Walker, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
Inequity of care provision and outcome disparity in autoimmune hepatitis in the United KingdomJessica K Dyson, Lin Lee Wong, Theophile Bigirumurame, et al.
Pageof 2